Igenius Life Science Llp Profile
Key Indicators
- Obligation of Contribution ₹ 6.50 Cr
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 20.05 Cr
About Igenius Life Science Llp
Igenius Life Science Llp (ILSL) is 10 Year, 2 Months old Limited Liability Partnership 18 November 2014. Its registered office is in Mahesana, Gujarat, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 6.50 Cr as per MCA.
Company Details
- Location
Mahesana, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN/FCRN
AAC-9326
- Incorporation Date
18 Nov 2014
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Ahmedabad
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Igenius Life Science Llp?
Designated Partners (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Minesh Suthar  | Designated Partner | 23-Mar-2017 | Current |
| Manish Patel | Designated Partner | 18-Nov-2014 | Current |
| Pravinbhai Patel | Designated Partner | 23-Mar-2017 | Current |
| Chintan Patel | Designated Partner | 18-Nov-2014 | Current |
| Raxit Patel | Designated Partner | 18-Nov-2014 | Current |
Financial Performance of Igenius Life Science Llp.
Enhance accessibility to Igenius Life Science Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Igenius Life Science Llp?
Unlock access to Igenius Life Science Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rebase Lifescience Private LimitedMinesh Suthar is a mutual person
Accufine Pharmaceuticals Private LimitedRaxit Patel is a mutual person
Vatsalya Research Laboratories Private LimitedMinesh Suthar is a mutual person
- Accufine Green Private Limited
Raxit Patel is a mutual person
Charges (Loans)
₹0
₹20.05 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 20.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2017 | State Bank Of India | ₹20.05 Cr | Satisfied |
How Many Employees Work at Igenius Life Science Llp?
Igenius Life Science Llp has a workforce of 54 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Igenius Life Science Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Igenius Life Science Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.